SecBot SecBot
6-K ·Filed May 14, 2026

GLAXF

GSK plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001654954-26-004863
Notable filing: 6-K
Actionable Insight • Neutral

This filing is purely administrative — no trading signal. Monitor GSK's next quarterly earnings or pipeline updates for material catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
GLAXF ▲ +0.62% at T+60d
NEUTRAL call +0.62% · α vs SPY -2.97% · entry $25.70 → $25.86
Entry = T+0 close
May 14, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.23%
$25.70
settled 6mo ago
T+5d
+1.17%
call +1.17% · α +1.89%
$26.00
settled 5mo ago
T+20d
+3.62%
call +3.62% · α +4.48%
$26.63
settled 5mo ago
T+60d
+0.62%
call +0.62% · α -2.97%
$25.86
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

GSK plc filed a Form 6-K reporting routine acquisitions of ordinary shares by multiple PDMRs (including the CFO, President of Europe, and others) under the company's Share Reward Plan on May 12, 2026. Each PDMR acquired a small number of partnership and matching shares at £18.6559 per share, with total individual holdings ranging from 12 to 14 shares. This is a standard administrative disclosure with no material financial or strategic impact.

Key Facts

  • Eight PDMRs and one PCA acquired ordinary shares under GSK's Share Reward Plan on May 12, 2026.
  • All transactions executed at £18.6559 per share on the London Stock Exchange.
  • Individual acquisitions ranged from 12 to 14 shares (partnership + matching shares).
  • No material financial data, guidance, or strategic changes disclosed.

Financial Impact

Total consideration across all transactions is approximately £223.87 (12 shares × £18.6559) to £261.18 (14 shares × £18.6559) per individual, an immaterial amount for a large-cap pharma company.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-004863
Document: 0001654954-26-004863-index-headers.html0001654954-26-004863
Document: 0001654954-26-004863-index.html0001654954-26-004863
Document: 0001654954-26-004863.txt0001654954-26-004863
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
20w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Open — Closes in 3h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026